Continuous activation of STAT3 in tumor-associated immune cells activates the expression of downstream genes VEGF, IL-10 and IL-6, and causes the proliferation of tumor-infiltrating hematopoietic stem cells, which ultimately leads to poor prognosis (Wang et al., 2018). The gene discussed is IL6; the disease is neoplasm.